Literature DB >> 3314665

The beta amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1.

V Blanquet1, D Goldgaber, C Turleau, N Créau-Goldberg, J Delabar, P M Sinet, M Roudier, J de Grouchy.   

Abstract

The beta amyloid protein gene (AD-AP) has been assigned by in situ hybridization to the vicinity of the 21q21-q22.1 interface, in a normal individual as well as in a patient with Alzheimer disease.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3314665

Source DB:  PubMed          Journal:  Ann Genet        ISSN： 0003-3995


  10 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

Review 3.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

4.  Distribution of meiotic recombination along nondisjunction chromosomes 21 in Down syndrome determined using cytogenetics and RFLP haplotyping.

Authors:  H Meijer; G J Hamers; R J Jongbloed; G P Vaes-Peeters; R R van der Hulst; J P Geraedts
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

5.  Selection of human chromosome 21-specific DNA probes for genetic analysis in Alzheimer's dementia and Down syndrome.

Authors:  G Van Camp; P Stinissen; W Van Hul; H Backhovens; A Wehnert; A Vandenberge; C Van Broeckhoven
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

Review 6.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

7.  Increased SOD1 enzymatic activity and gene modifications in orangutans: evolutionary implications.

Authors:  J de Grouchy; A Nicole; C Cochet; P M Sinet; N Créau-Goldberg
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

8.  Synthesis and bioassay of β-(1,4)-D-mannans as potential agents against Alzheimer's disease.

Authors:  Ru-wei Jiang; Xiao-guang Du; Xuan Zhang; Xin Wang; Ding-yu Hu; Tao Meng; Yue-lei Chen; Mei-yu Geng; Jing-kang Shen
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

Review 9.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

Review 10.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude Wischik; Patrick R Hof
Journal:  Biomolecules       Date:  2016-01-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.